Oncogenic Signaling Pathways in The Cancer Genome Atlas
2018 · Cell · 3,293 citations
https://doi.org/10.1016/j.cell.2018.03.035
S
Steven M. Foltz
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
134
Papers
6.4K
Citations
22
h-index
25
i10-index
Steven M. Foltz is an academic researcher. The author has contributed to research in topics: Multiple Myeloma Research and Treatments & Protein Degradation and Inhibitors & Cancer Genomics and Diagnostics. The author has an h-index of 22, co-authored 114 publications.
ORCID: 0000-0002-9526-8194Papers by this author
worksIntegrated Proteogenomic Characterization of Clear Cell Renal Cell Carcinoma
2019 · Cell · 745 citations
https://doi.org/10.1016/j.cell.2019.10.007
Driver Fusions and Their Implications in the Development and Treatment of Human Cancers
2018 · Cell Reports · 633 citations
https://doi.org/10.1016/j.celrep.2018.03.050
Co-evolution of tumor and immune cells during progression of multiple myeloma
2021 · Nature Communications · 135 citations
https://doi.org/10.1038/s41467-021-22804-x
Proteogenomic Characterization of Ovarian HGSC Implicates Mitotic Kinases, Replication Stress in Observed Chromosomal Instability
2020 · Cell Reports Medicine · 95 citations
https://doi.org/10.1016/j.xcrm.2020.100004
Pan-cancer proteogenomics connects oncogenic drivers to functional states
2023 · Cell · 91 citations
https://doi.org/10.1016/j.cell.2023.07.014
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat